Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AQNEURSA safely and effectively. See full prescribing information for AQNEURSA. AQNEURSA™ (levacetylleucine) for oral suspension Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
AQNEURSA™ is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg.
- generic_name
- levacetylleucine
- product_names
- levacetylleucine
- ndc
- 83853-101, 83853-101-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en